Bionik Laboratories Secures Hong Kong Distribution Agreement

Robotics company, Bionik Laboratories (OTCPINK: BNKL) has entered into a distribution agreement with Pro-Med Technology for the sale of InMotion® robotic devices in Hong Kong.

The agreement will enable Bionik to further expand its footprint in Asia through Pro-Med’s sales and distribution network.


The agreement between Bionik and Pro-Med Technology will grant Pro-Med exclusive rights to market and sell Bionik’s InMotion® Arm/Hand robotic device in Hong Kong. Pro-Med is a leading provider of medical equipment based in Hong Kong.

Bionik’s InMotion® robots are used in rehabilitation following stroke and other neurological conditions to help patients regain arm and hand movement.

Extensive clinical data has demonstrated that the InMotion® robots provide more effective patient outcomes than traditional therapy alone.

Bionik InMotion® devices are now present across 20 countries worldwide. 

About Bionik

Bionik Laboratories is a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility challenges. The company offers its technology to therapists directly and offers services to patients in its clinical centers. Bionik has a portfolio of products focused on upper and lower extremity rehabilitation for stroke and other mobility-impaired patients, including three products on the market and three products in varying stages of development.


This communication was produced by Prism MarketView, an affiliate of PCG Advisory Inc., (together “PCG”). PCG is an integrated investor relations, communications and strategic advisory firm. The information contained on this is ‘Paid Advertising’ for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations there under, the “Securities Act”). “PCG” and its affiliates are compensated by respective clients for publicizing information relating to its client’s securities. For more information in terms of compensation received for services provided by PCG, see the pertinent advertising materials relating to the respective client. By accessing this Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy…

Read Full Disclaimer

Share This Article


About the Author

Bionik Laboratories Secures Hong Kong Distribution Agreement

Editor Prism MarketView